USPTO 2015–2025 USPTO PatentsView US Corporation

Pain TEQ, LLC

USPTO PatentsView assignee record - 12 granted patents across 2 technology areas, recorded in grant years 2021–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Pain ranks #23,162 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 2 technology areas.

#23,162
of 49,997 US assignees by volume
Top 45%
by Innovation Score (36.8/100)
16.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R23162 · US Corporation #23,162 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 12 grants
  • MID-PACK #23,162/49,997
  • PHOTO-FINISH Pacific Tech…
  • CPC-NARROW A61B · 2 areas
  • INNOV-THIN 36.8/100
  • CLAIMS-RICH 16.0 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2021–2023 · 3y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Pacific Tech Industries, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Pain’s 36.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Pain

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Pain's Innovation Score is 36.8/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Pain?

Each dot is one of Pain’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Pain’s own 16.0 claims/patent is ABOVE the 15.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Pain vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 11.911.91212.1 51015202530 Granted patents (volume) Avg claims / patent Protrend Co., Ltd. - 12, 8.08ProtrendPulike Biological Engineering, Inc. - 12, 11.75Pulike Biological…Pyrogenesis Canada Inc. - 12, 15.83Pyrogenesis CanadaPacific Tech Industries, Inc. - 12, 18.42Pacific Tech Indu…Panera, LLC - 12, 22.17PaneraPapeltec Overseas, Inc. - 12, 16.33Papeltec OverseasParker Hannifin Manufacturing (UK) Ltd. - 12, 25.58Parker Hannifin M…Parker Hannifin Manufacturing France - 12, 13.42Parker Hannifin M…Pain TEQ, LLC - 12, 16Pain TEQ
Pain vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Pain's grants concentrate

Pain TEQ, LLC is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (5 grants) versus a trough of 3 in 2023. By volume, Pain sits between Protrend Co., Ltd. and Parker Hannifin Manufacturing France.

Pain's three-year grant acceleration

Pain TEQ, LLC shows 8 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Pain's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Pain holds 12 patents at rank #23,189, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Pain

By rank, the assignees closest to #23,189 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Pain's primary technology class.

Pain's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 45% higher than 55% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

2.533.544.555.5 202120222023 3
USPTO utility patent grants by year · 2021–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Pain TEQ, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 4 33.3%
2022 5 41.7%
2023 3 25.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Pain TEQ, LLC's patent record in context - here's where to go next.

  • Pain TEQ, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #23,162 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Pain TEQ, LLC against Protrend Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 36.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.